We have another teaser….this morning, Schultze Special Purpose Acquisition Corp. (SAMA), announced ahead of their forthcoming deadline extension vote that they have signed a non-binding LOI with Clever Leaves, a multi-national cannabis operator.
Interestingly, this is not a teaser where the SPAC makes you guess who they’re buying. Instead, SAMA is stating exactly who it is they’re negotiating with and have even provide quotes from Clever Leave’s CEO. This deal sounds fully-baked and yet they still do not have signed a definitive agreement. Perhaps Clever Leaves is waiting to see the results of the extension vote and how much cash is left in trust before they commit to terms. However, without a signed definitive agreement, we can’t technically move SAMA into the “announced” column just yet.
Nevertheless, today’s press release did provide some information on the intended target. Clever Leaves operates globally with operations and facilities in Colombia, Portugal, the United States, Canada and Germany, producing pharmaceutical grade cannabis. The Company currently cultivates in over 1.9 million square feet of greenhouses, making it one of the largest cannabis cultivation and extraction companies globally. Clever Leaves is also in the process of becoming one of the few cannabis companies in the world, and the only cannabis company in Latin America, to be granted a European Union Good Manufacturing Practice (“EU GMP”) certification for extracts, subject to successful completion of the certification process.
We currently have seven cannabis-focused SPACs out searching for targets, but it appears SAMA, which initially intended to focus on restructured companies, beat them all to announcing a cannabis combination. To-date, only MTech (now Akerna – KERN) has closed a cannabis combination. Although, Akerna was only “cannabis-adjacent” since it provided compliance technology to the sector, i.e., it was not involved in production or distribution. If SAMA does “definitively” announce and this looks like a good deal, this could be the shot in the arm the rest of the field needs to announce their own cannabis deals. A “contact high”, so to speak.
SAMA goes to a vote next Tuesday, June 9th, and it sounds like we can expect a full announcement and definitive agreement shortly thereafter. We’ll have to wait and see.
Terms Tracker for the Week Ending March 24, 2023 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. While this week was relatively quiet on the filings front, we did see March’s second SPAC IPO price with Oak Woods Acquisition Corp’s $50 million...
Latest Non-Redemption Agreements: ExcelFin Acquisition Corp. ExcelFin Acquisition Corp. (XFIN) Adds Non-Redemption Agreement In connection with the special meeting of stockholders of ExcelFin Acquisition Corp. (NASDAQ:XFIN) to extend its completion deadline from April 25, 2023 to October 25, 2023, the company and its sponsor, ExcelFin SPAC LLC, entered into a non-redemption agreement with an unaffiliated third party....
Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. Latest SPAC News: Momentus SPAC backers accused of deliberately engineering a catastrophic deal Momentus SPAC Backers Accused of Hiding Disastrous Deal’s Flaws A Momentus Inc. (NASDAQ:MNTS) investor sued backers of its blank-check merger with a shell company,...
DiamondHead Holdings Corp. (NASDAQ:DHHC) announced in an 8-K this morning that its shareholders approved its combination with Great Southern Homes at a special meeting March 23. Only 109,426 shares were redeemed in the connection with the vote, but DiamondHead has seen about 87% redemptions in total across all previous votes, leaving it with about $43.9...
Graf Acquisition Corp. IV (NYSE:GFOR) announced that it has signed a non-binding letter of intent to combine with clinical-stage biopharma company NKGen. This announcement is not a pure teaser as Graf IV is not facing an imminent extension vote and currently has until May 25 on its clock. It does, however, signal something of a...